NovAccess Global Inc. (XSNX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0001 (-50.00%)
Sep 10, 2025, 2:58 PM EDT
NovAccess Global Market Cap
NovAccess Global has a market cap or net worth of $6.19 thousand as of September 12, 2025. Its market cap has decreased by -99.05% in one year.
Market Cap
6.19K
Enterprise Value
7.03M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 18, 1998, NovAccess Global's market cap has decreased from 26.88M to 6.19K, a decrease of -99.98%. That is a compound annual growth rate of -26.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 10, 2025 | 6.19K | -99.00% |
Dec 31, 2024 | 619.07K | 28.89% |
Dec 29, 2023 | 480.31K | -91.60% |
Dec 30, 2022 | 5.72M | 10.69% |
Dec 31, 2021 | 5.17M | 66.44% |
Dec 31, 2020 | 3.10M | 287.51% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nika Pharmaceuticals | 982.68M |
Veradigm | 815.18M |
Elite Pharmaceuticals | 739.37M |
Tian'an Technology Group | 675.94M |
Glass House Brands | 608.81M |
CytoDyn | 424.27M |
Northwest Biotherapeutics | 378.39M |
American Oncology Network | 353.52M |